UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | P | R | S | T | U | V | W | Z
Number of items: 158.

A

Abou-Sleiman, PM; Healy, DG; Ahmadi, K; Goldstein, DB; Wood, NW; (2003) Population genetic approaches to Parkinsons disease. In: AMERICAN JOURNAL OF HUMAN GENETICS. (pp. 541 - 541). UNIV CHICAGO PRESS

Abou-Sleiman, PM; Healy, DG; Quinn, N; Lees, AJ; Wood, NW; (2003) The role of pathogenic DJ-1 mutations in Parkinson's disease. ANN NEUROL , 54 (3) 283 - 286. 10.1002/ana.10675.

Abramov, A.Y.; Canevari, L.; Duchen, M.R.; (2003) Changes in intracellular calcium and glutathione in astrocytes as the primary mechanism of amyloid neurotoxicity. Nature Chemical Biology , 23 (12) pp. 5088-5095. Green open access
file

Abramov, AY; Canevari, L; Duchen, MR; (2003) Amyloid beta peptide causes [Ca2+](c) fluctuations and decreases [GSH] in rat astrocytes. In: BIOPHYSICAL JOURNAL. (pp. 389A - 389A). BIOPHYSICAL SOCIETY

Abramov, AY; Canevari, L; Duchen, MR; (2003) Changes in intracellular calcium and glutathione in astrocytes as the primary mechanism of amyloid neurotoxicity. J NEUROSCI , 23 (12) 5088 - 5095.

Abramov, AY; Duchen, MR; (2003) Actions of ionomycin, 4-BrA23187 and a novel electrogenic Ca2+ ionophore on mitochondria in intact cells. CELL CALCIUM , 33 (2) 101 - 112.

Ahmad-Annuar, A; Shah, P; Hafezparast, M; Hummerich, H; Witherden, AS; Morrison, KE; ... Fisher, EMC; + view all (2003) No association with common Caucasian genotypes in exons 8, 13 and 14 of the human cytoplasmic dynein heavy chain gene (DNCHC1) and familial motor neuron disorders. AMYOTROPH LATERAL SC , 4 (3) 150 - 157.

Alves, JD; Ames, PRJ; Donohue, S; Stanyer, L; Nourooz-Zadeh, J; Ravirajan, C; Isenberg, DA; (2003) Antibodies to high-density lipoprotein and beta(2)-glycoprotein I are inversely correlated with paraoxonase activity in systematic lupus erythematosus (vol 46, pg 2686, 2002). ARTHRITIS RHEUM , 48 (1) 284 - 284. 10.1002/art.539.

Andorfer, C; Kress, Y; Espinoza, M; de Silva, R; Tucker, KL; Barde, YA; ... Davies, P; + view all (2003) Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoforms. J NEUROCHEM , 86 (3) 582 - 590. 10.1046/j.1471-4159.2003.01879.x.

B

Baptista, MJ; O'Farrell, C; Daya, S; Ahmad, R; Miller, DW; Hardy, J; ... Cookson, MR; + view all (2003) Co-ordinate transcriptional regulation of dopamine synthesis genes by alpha-synuclein in human neuroblastoma cell lines. JOURNAL OF NEUROCHEMISTRY , 85 (4) 957 - 968. 10.1046/j.1471-4159.2003.01742.x.

Baptista, MJ; O'Farrell, C; Hardy, J; Cookson, MR; (2003) Microarray analysis reveals induction of heat shock proteins mRNAs by the torsion dystonia protein, TorsinA. NEUROSCIENCE LETTERS , 343 (1) 5 - 8. 10.1016/S0304-3940(03)00302-1.

Baumann, M; Mamais, A; McBlane, F; Xiao, H; Boyes, J; (2003) Regulation of V(D)J recombination by nucleosome positioning at recombination signal sequences. EMBO J , 22 (19) 5197 - 5207.

Boreström, C; Zetterberg, H; Liff, K; Rymo, L; (2003) Functional interaction of nuclear factor y and sp1 is required for activation of the epstein-barr virus C promoter. J Virol , 77 (2) 821 - 829.

Brancati, F; Valente, EM; Davies, NP; Sarkozy, A; Sweeney, MG; LoMonaco, M; ... Dallapiccola, B; + view all (2003) Severe infantile hyperkalaemic periodic paralysis and paramyotonia congenita: broadening the clinical spectrum associated with the T704M mutation in SCN4A. J NEUROL NEUROSUR PS , 74 (9) 1339 - 1341.

C

Cairns, NJ; Perry, RH; Jaros, E; Burn, D; McKeith, IG; Lowe, JS; ... Lantos, PL; + view all (2003) Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions. NEUROSCI LETT , 341 (3) 177 - 180. 10.1016/S0304-3940(03)00100-9.

Church, AJ; Dale, RC; Cardoso, F; Candler, PM; Chapman, MD; Allen, ML; ... Giovannoni, G; + view all (2003) CSF and serum immune parameters in Sydenham's chorea: evidence of an autoimmune syndrome? J NEUROIMMUNOL , 136 (1-2) 149 - 153. 10.1016/S0165-5728(03)00012-2.

Church, AJ; Dale, RC; Lees, AJ; Giovannoni, G; Robertson, MM; (2003) Tourette's syndrome: a cross sectional study to examine the PANDAS hypothesis. J NEUROL NEUROSUR PS , 74 (5) 602 - 607.

Colosimo, C; Hughes, AJ; Kilford, L; Lees, AJ; (2003) Lewy body cortical involvement may not always predict dementia in Parkinson's disease. J NEUROL NEUROSUR PS , 74 (7) 852 - 856.

Colosimo, C; Osaki, Y; Vanacore, N; Lees, AJ; (2003) Lack of association between progressive supranuclear palsy and arterial hypertension: A clinicopathological study. MOVEMENT DISORDERS , 18 (6) 694 - 697. 10.1002/mds.10392.

Cordivari, C; Vincent, A; Misra, VP; Catania, S; Murray, NMF; Bhatia, KP; Lees, AJ; (2003) Failure to identify change in the cervical dystonia muscle pattern is the main cause of reduced response to BTXA. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 408 - 409). BRITISH MED JOURNAL PUBL GROUP

D

Dabrowski, M; Aerts, S; Van Hummelen, P; Craessaerts, K; De Moor, B; Annaert, W; ... De Strooper, B; + view all (2003) Gene profiling of hippocampal neuronal culture. J Neurochem , 85 (5) 1279 - 1288.

Davies, NA; Cochrane, G; Hanna, M; (2003) Muscle disorders. In: Greenwood, RJ and Barnes, MP and McMillan, TM and Ward, CD, (eds.) Handbook of neurological rehabilitation. (705 - 725). Psychology Press: Hove.

Davies, NP; Hanna, MG; (2003) The skeletal muscle channelopathies: distinct entities and overlapping syndromes. CURR OPIN NEUROL , 16 (5) 559 - 568. 10.1097/01.wco.0000093098.34793.09.

de Silva, R; Hope, A; Pittman, A; Weale, ME; Morris, HR; Wood, NW; Lees, AJ; (2003) Strong association of the Saitohin gene Q7 variant with progressive supranuclear palsy. NEUROLOGY , 61 (3) 407 - 409.

de Silva, R; Lashley, T; Gibb, G; Hanger, D; Hope, A; Reid, A; ... Lees, A; + view all (2003) Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies. NEUROPATH APPL NEURO , 29 (3) 288 - 302.

de Silva, R.; Lashley, T.; Gibb, G.; Hanger, D.; Hope, A.; Reid, A.; ... Lees, A.; + view all (2003) Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule-binding repeat domains as demonstrated by new specific monoclonal antibodies. Neuropathology and Applied Neurobiology , 29 (3) pp. 288-302. 10.1046/j.1365-2990.2003.00463.x.

De Strooper, B; (2003) Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex. Neuron , 38 (1) 9 - 12.

De Strooper, B; Woodgett, J; (2003) Alzheimer's disease: Mental plaque removal. Nature , 423 (6938) 392 - 393. 10.1038/423392a.

Doder, M; Rabiner, EA; Turjanski, N; Lees, AJ; Brooks, DJ; (2003) Tremor in Parkinson's disease and serotonergic dysfunction - An (11)C-WAY 100635 PET study. NEUROLOGY , 60 (4) 601 - 605.

E

Edwards, M; Wood, N; Bhatia, K; (2003) Unusual phenotypes in DYT1 dystonia: A report of five cases and a review of the literature. MOVEMENT DISORD , 18 (6) 706 - 711. 10.1002/mds.10411.

Edwards, M; Wood, N; Bhatia, K; (2003) Unusual phenotypes in DYT1 dystonia: A report of five cases and a review of the literature. Movement Disorders , 18 (6) 706 - 711.

Edwards, M.J.; Huang, Y.-Z.; Wood, N.W.; Rothwell, J.C.; Bhatia, K.P.; (2003) Different patterns of electrophysiological deficits in manifesting and non-manifesting carriers of the DYT1 gene mutation. Brain , 126 (9) pp. 2074-2080. 10.1093/brain/awg209.

Edwards, MJ; Huang, YZ; Wood, NW; Rothwell, JC; Bhatia, KP; (2003) Different patterns of electrophysiological deficits in manifesting and non-manifesting carriers of the DYT1 gene mutation. BRAIN , 126 2074 - 2080. 10.1093/brain/awg209.

Eerola, J; Hernandez, D; Launes, J; Hellstrom, O; Hague, S; Gulick, C; ... Singleton, AB; + view all (2003) Assessment of a DJ-1 (PARK7) polymorphism in Finnish PD. NEUROLOGY , 61 (7) 1000 - 1002.

El-Agnaf, OMA; Salem, SA; Paleologou, KE; Cooper, LJ; Fullwood, NJ; Gibson, MJ; ... Allsop, D; + view all (2003) alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma. FASEB JOURNAL , 17 (11) 1945 - +. 10.1096/fj.03-0098fje.

Emre, M; Lees, AJ; (2003) Parkinsonism and dementia: Synucleinopathies, tauopathies and beyond - Introduction. MOVEMENT DISORDERS , 18 S1 - S1. 10.1002/mds.10556.

F

Frank, RA; Galasko, D; Hampel, H; Hardy, J; de Leon, MJ; Mehta, PD; ... Trojanowski, JQ; + view all (2003) Biological markers for therapeutic trials in Alzheimer's disease - Proceedings of the biological markers working group; NIA initiative on neuroimaging in Alzheimer's disease. NEUROBIOLOGY OF AGING , 24 (4) 521 - 536. 10.1016/S0197-4580(03)00002-2.

G

Gerschlager, W; Katzenschlager, R; Schrag, A; Lees, AJ; Brown, P; Quinn, N; Bhatia, KP; (2003) Quality of life in patients with orthostatic tremor. J NEUROL , 250 (2) 212 - 215. 10.1007/s00415-003-0980-9.

Gibson, GE; Kingsbury, AE; Xu, H; Lindsay, JG; Daniel, S; Foster, OJF; ... Blass, JP; + view all (2003) Deficits in a tricarboxylic acid cycle enzyme in brains from patients with Parkinson's disease. NEUROCHEMISTRY INTERNATIONAL , 43 (2) 129 - 135. 10.1016/S0197-0186(02)00225-5.

Goldstein, D.B.; Ahmadi, K.R.; Weale, M.E.; Wood, N.W.; (2003) Genome scans and candidate gene approaches in the study of common diseases and variable drug responses. Trends in Genetics , 19 (11) pp. 615-622. 10.1016/j.tig.2003.09.006.

Goldstein, DB; Ahmadi, KR; Weale, ME; Wood, NW; (2003) Genome scans and candidate gene approaches in the study of common diseases and variable drug responses. TRENDS GENET , 19 (11) 615 - 622. 10.1016/j.tig.2003.09.006.

Grover, A; England, E; Baker, M; Sahara, N; Adamson, J; Granger, B; ... Hutton, M; + view all (2003) A novel tau mutation in exon 9 (1260V) causes a four-repeat tauopathy. EXP NEUROL , 184 (1) 131 - 140. 10.1016/S0014-4886(03)00393-5.

Groves, MJ; Schanzer, A; Simpson, AJ; An, SF; Kuo, LT; Scaravilli, F; (2003) Profile of adult rat sensory neuron loss, apoptosis and replacement after sciatic nerve crush. J NEUROCYTOL , 32 (2) 113 - 122.

H

Hadjivassiliou, M; Grunewald, R; Sharrack, B; Sanders, D; Lobo, A; Williamson, C; ... Davies-Jones, A; + view all (2003) Gluten ataxia in perspective: epidemiology, genetic susceptibility and clinical characteristics. BRAIN , 126 685 - 691. 10.1093/brain/awg050.

Hague, S; Rogaeva, E; Hernandez, D; Gulick, C; Singleton, A; Hanson, M; ... Singleton, A; + view all (2003) Early-onset Parkinson's disease caused by a compound heterozygous DJ-1 mutation. ANNALS OF NEUROLOGY , 54 (2) 271 - 274. 10.1002/ana.10663.

Hanna, M; (2003) Disorders of muscle: introduction. In: Warrell, DA and Cox, TM and Firth, JD and Benz, EJ, (eds.) Oxford Textbook of Medicine. (1216 - 1220). Oxford University Press: Oxford.

Hardy, J; (2003) Alzheimer's disease: Genetic evidence points to a single pathogenesis. ANNALS OF NEUROLOGY , 54 (2) 143 - 144. 10.1002/ana.10624.

Hardy, J; (2003) Impact of genetic analysis on Parkinson's disease research. In: MOVEMENT DISORDERS. (pp. S96 - S98). WILEY-LISS

Hardy, J; (2003) The relationship between amyloid and tau. JOURNAL OF MOLECULAR NEUROSCIENCE , 20 (2) 203 - 206. 10.1385/JMN:20:2:203.

Hardy, J; (2003) The relationship between Lewy body disease, Parkinson's disease, and Alzheimer's disease. Annals of the New York Academy of Sciences , 991 167 - 170.

Hardy, J; Cookson, MR; Singleton, A; (2003) Genes and parkinsonism. LANCET NEUROLOGY , 2 (4) 221 - 228. 10.1016/S1474-4422(03)00350-8.

Hardy, J; Singleton, A; Gwinn-Hardy, K; (2003) Ethnic differences and disease phenotypes. SCIENCE , 300 (5620) 739 - 740. 10.1126/science.300.5620.739.

Hargreaves, IP; Heales, SJR; Briddon, A; Lee, PJ; Hanna, MG; Land, JM; (2003) Primary pyruvate dehydrogenase E3 binding protein deficiency with mild hyperlactataemia and hyperalaninaemia. J INHERIT METAB DIS , 26 (5) 505 - 506.

Harold, D; Peirce, T; Moskvina, V; Myers, A; Jones, S; Hollingworth, P; ... Jones, L; + view all (2003) Sequence variation in the CHAT locus shows no association with late-onset Alzheimer's disease. HUMAN GENETICS , 113 (3) 258 - 267. 10.1007/s00439-003-0960-2.

Hernandez, D; Hanson, M; Singleton, A; Gwinn-Hardy, K; Freeman, J; Ravina, B; ... Singleton, A; + view all (2003) Mutation at the SCA17 locus is not a common cause of parkinsonism. PARKINSONISM & RELATED DISORDERS , 9 (6) 317 - 320. 10.1016/S1353-8020(03)00027-0.

Herreman, A; Van Gassen, G; Bentahir, M; Nyabi, O; Craessaerts, K; Annaert, W; ... Mueller, U; + view all (2003) γ-Secretase activity requires the presenilin-dependent trafficking of nicastrin through the Golgi apparatus but not its complex glycosylation. Journal of Cell Science , 116 (6) 1127 - 1136. 10.1242/jcs.00292.

Herreman, A; Van Gassen, G; Bentahir, M; Nyabi, O; Craessaerts, K; Mueller, U; ... De Strooper, B; + view all (2003) gamma-Secretase activity requires the presenilin-dependent trafficking of nicastrin through the Golgi apparatus but not its complex glycosylation. J Cell Sci , 116 (Pt 6) 1127 - 1136.

Hogg, M; Grujic, ZM; Baker, M; Demirci, S; Guillozet, AL; Sweet, AP; ... Bigio, EH; + view all (2003) The L266V tau mutation is associated with frontotemporal dementia and Pick-like 3R and 4R tauopathy. ACTA NEUROPATHOL , 106 (4) 323 - 336. 10.1007/s00401-003-0734-x.

Holton, JL; Beesley, C; Winchester, B; Al-Memar, A; (2003) Vacuolar myopathy in twin girls. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY , 29 (5) 525 - 525.

Hope, AD; de Silva, R; Fischer, DF; Hol, EM; van Leeuwen, FW; Lees, AJ; (2003) Alzheimer's associated variant ubiquitin causes inhibition of the 26S proteasome and chaperone expression. J NEUROCHEM , 86 (2) 394 - 404. 10.1046/j.1471-4159.2003.01844.x.

Houlden, H; Lincoln, S; Farrer, M; Cleland, PG; Hardy, J; Orrell, RW; (2003) Compound heterozygous PANK2 mutations confirm HARP and Hallervorden-Spatz syndromes are allelic. NEUROLOGY , 61 (10) 1423 - 1426.

Houlden, H.; Lincoln, S.; Farrer, M.; Cleland, P.G.; Hardy, J.; Orrell, R.W.; (2003) Compound heterozygous PANK2 mutations confirm HARP and Hallervorden-Spatz syndromes are allelic. Neurology , 61 (10) pp. 1423-1426.

I

Iseki, E; Togo, T; Suzuki, K; Katsuse, O; Marui, W; de Silva, R; ... Kosaka, K; + view all (2003) Dementia with Lewy bodies from the perspective of tauopathy. ACTA NEUROPATHOL , 105 (3) 265 - 270. 10.1007/s00401-002-0644-3.

J

Janssen, JC; Beck, JA; Campbell, TA; Dickinson, A; Fox, NC; Harvey, RJ; ... Collinge, J; + view all (2003) Early onset familial Alzheimer's disease - Mutation frequency in 31 families. NEUROLOGY , 60 (2) 235 - 239.

Johansson, A; Hampel, H; Faltraco, F; Buerger, K; Minthon, L; Bogdanovic, N; ... Blennow, K; + view all (2003) Increased frequency of a new polymorphism in the cell division cycle 2 (cdc2) gene in patients with Alzheimer's disease and frontotemporal dementia. Neurosci Lett , 340 (1) 69 - 73.

Josephs, K.A.; Holton, J.L.; Rossor, M.N.; Braendgaard, H.; Ozawa, T.; Fox, N.C.; ... Revesz, T.; + view all (2003) Neurofilament inclusion body disease: a new proteinopathy? Brain , 126 (10) pp. 2291-2303. 10.1093/brain/awg231.

Josephs, KA; Holton, JL; Rossor, MN; Braendgaard, H; Ozawa, T; Fox, NC; ... Revesz, T; + view all (2003) Neurofilament inclusion body disease. In: ANNALS OF NEUROLOGY. (pp. S51 - S51). WILEY-LISS

Josephs, KA; Holton, JL; Rossor, MN; Braendgaard, H; Ozawa, T; Fox, NC; ... Revesz, T; + view all (2003) Neurofilament inclusion body disease: a new proteinopathy? BRAIN , 126 2291 - 2303. 10.1093/brain/awg231.

Josephs, KA; Holton, JL; Rossor, MN; Braendgaard, H; Petersen, RC; Pearl, GS; ... Revesz, T; + view all (2003) Neurofilament inclusion body disease: a new proteinopathy. NEUROPATH APPL NEURO , 29 (5) 521 - 521.

K

Kahle, PJ; De Strooper, B; (2003) Attack on amyloid. EMBO Rep , 4 (8) 747 - 751. 10.1038/sj.embor.embor905.

Katsuse, O; Iseki, E; Arai, T; Akiyama, H; Togo, T; Uchikado, H; ... Kosaka, K; + view all (2003) 4-repeat tauopathy sharing pathological and biochemical features of corticobasal degeneration and progressive supranuclear palsy. ACTA NEUROPATHOL , 106 (3) 251 - 260. 10.1007/s00401-003-0728-8.

Katzenschlager, R; Cardozo, A; Cobo, MRA; Tolosa, E; Lees, AJ; (2003) Unclassifiable parkinsonism in two European tertiary referral centres for movement disorders. MOVEMENT DISORD , 18 (10) 1123 - 1131. 10.1002/mds.10523.

Katzenschlager, R; Costa, D; Gerschlager, W; O'Sullivan, J; Zijlmans, J; Gacinovic, S; ... Brown, P; + view all (2003) [I-123]-FP-CIT-SPECT demonstrates dopaminergic deficit in orthostatic tremor. ANN NEUROL , 53 (4) 489 - 496. 10.1002/ana.10475.

Katzenschlager, R; Costa, D; Gerschlager, W; O'Sullivan, J; Zijlmans, J; Gacinovic, S; ... Brown, P; + view all (2003) [I-12]-FP-CIT-SPECT demonstrates dopaminergic deficit in orthostatic tremor. (vol 53, pg 489, 2003). ANNALS OF NEUROLOGY , 54 (2) 278 - 278.

Katzenschlager, R; Sampaio, C; Costa, J; Lees, A; (2003) Anticholinergics for symptomatic management of Parkinson's disease. Cochrane Database Syst Rev (2) CD003735 - ?. 10.1002/14651858.CD003735.

Khan, N.L.; Graham, E.; Critchley, P.; Schrag, A.E.; Wood, N.W.; Lees, A.J.; ... Quinn, N.; + view all (2003) Parkin disease: a phenotypic study of a large case series. Brain , 126 (6) pp. 1279-1292. 10.1093/brain/awg142.

Khan, NL; Graham, E; Critchley, P; Schrag, AE; Wood, NW; Lees, AJ; ... Quinn, N; + view all (2003) Parkin disease: a phenotypic study of a large case series. BRAIN , 126 1279 - 1292. 10.1093/brain/awg142.

Khan, NL; Wood, NW; Bhatia, KP; (2003) Autosomal recessive, DYT2-like primary torsion dystonia - A new family. NEUROLOGY , 61 (12) 1801 - 1803.

Kuo, L; Scaravilli, F; Groves, MJ; An, SF; (2003) Gene expression of neurotrophins and their receptors in the dorsal root ganglion after axotomy and systemic NT-3 treatment. In: JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. (pp. 578 - 578). AMER ASSN NEUROPATHOLOGISTS INC

Kuoppamaki, M; Giunti, P; Quinn, N; Wood, NW; Bhatia, KP; (2003) Slowly progressive cerebellar ataxia and cervical dystonia: Clinical presentation of a new form of spinocerebellar ataxia? MOVEMENT DISORD , 18 (2) 200 - 206. 10.1002/mds.10308.

L

Lang, AE; Lees, AJ; (2003) Untitled. MOVEMENT DISORDERS , 18 (1) 1 - 1. 10.1002/mds.10410.

Lauwers, E; Debyser, Z; Van Dorpe, J; De Strooper, B; Nuttin, B; Baekelandt, V; (2003) Neuropathology and neurodegeneration in rodent brain induced by lentiviral vector-mediated overexpression of alpha-synuclein. Brain Pathol , 13 (3) 364 - 372.

Lawrence, AD; Evans, AH; Lees, AJ; (2003) Compulsive use of dopamine replacement therapy in Parkinson's disease: reward systems gone awry? LANCET NEUROL , 2 (10) 595 - 604.

Lee, M.-J.; Stephenson, D.A.; Groves, M.J.; Sweeney, M.G.; Davis, M.B.; An, S.-F.; ... Reilly, M.M.; + view all (2003) Hereditary sensory neuropathy is caused by a mutation in the delta subunit of the cytosolic chaperonin-containing t-complex peptide-1 (Cct4 ) gene. Human Molecular Genetics , 12 (15) pp. 1917-1925. 10.1093/hmg/ddg198.

Lee, MJ; Stephenson, DA; Groves, MJ; Sweeney, MG; Davis, MB; An, SF; ... Reilly, MM; + view all (2003) Hereditary sensory neuropathy is caused by a mutation in the delta subunit of the cytosolic chaperonin-containing t-complex peptide-1 (Cct4) gene. HUM MOL GENET , 12 (15) 1917 - 1925. 10.1093/hmg/ddg198.

Lees, AJ; (2003) Parkinson's syndrome associated with neurofibrillary degeneration and tau pathologic findings. In: MOVEMENT DISORDERS. (pp. S28 - S33). WILEY-LISS

Lees, AJ; (2003) Parkinson's syndrome associated with neurofibrillary degeneration and tau pathologic findings. Mov Disord , 18 Suppl 6 S28 - S33. 10.1002/mds.10560.

Lees, AJ; Grosset, DG; (2003) Dopamine transporter imaging. Movement Disorders , 18 (Suppl.) S1 - S2.

Lees, AJ; Grosset, DG; (2003) Dopamine transporter imaging - Introduction. MOVEMENT DISORDERS , 18 S1 - S2. 10.1002/mds.10570.

Leigh, PN; Ludolph, AC; Payan, CAM; Graf, M; Lacomblez, L; Vidailhet, M; ... Grp, NNIPPSS; + view all (2003) Cross-sectional clinical description of a large prospective cohort of patients with progressive supranuclear palsy or multiple system atrophy: The NNIPPS project. In: ANNALS OF NEUROLOGY. (pp. S70 - S71).

Lhatoo, SD; Perunovic, B; Love, S; Houlden, H; Campbell, MJ; (2003) Familial idiopathic brain calcification - A new and familial alpha-synucleinopathy? EUR NEUROL , 49 (4) 223 - 226. 10.1159/000070189.

Lichtenthaler, SF; Dominguez, DI; Westmeyer, GG; Reiss, K; Haass, C; Saftig, P; ... Seed, B; + view all (2003) The cell adhesion protein P-selectin glycoprotein ligand-1 is a substrate for the aspartyl protease BACE1. J Biol Chem , 278 (49) 48713 - 48719. 10.1074/jbc.M303861200.

Lincoln, S; Wiley, J; Lynch, T; Langston, JW; Chen, R; Lang, A; ... Farrer, M; + view all (2003) Parkin-proven disease - Common founders but divergent phenotypes. NEUROLOGY , 60 (10) 1605 - 1610.

Lincoln, SJ; Maraganore, DM; Lesnick, TG; Bounds, R; de Andrade, M; Bower, JH; ... Farrer, MJ; + view all (2003) Parkin variants in north American Parkinson's disease: Cases and controls. MOVEMENT DISORDERS , 18 (11) 1306 - 1311. 10.1002/mds.10601.

Liolitsa, D; Rahman, S; Benton, S; Carr, LJ; Hanna, MG; (2003) Is the mitochondrial complex IND5 gene a hot-spot for MELAS causing mutations? ANN NEUROL , 53 (1) 128 - 132. 10.1002/ana.10435.

Lohmann, E; Periquet, M; Bonifati, V; Wood, NW; De Michele, G; Bonnet, AM; ... European Consortium Genetic Suscep,; + view all (2003) How much phenotypic variation can be attributed to parkin genotype? ANN NEUROL , 54 (2) 176 - 185. 10.1002/ana.10613.

M

Maraganore, DM; de Andrade, M; Lesnick, TG; Farrer, MJ; Bower, JH; Hardy, JA; Rocca, WA; (2003) Complex interactions in Parkinson's disease: A two-phased approach. MOVEMENT DISORDERS , 18 (6) 631 - 636. 10.1002/mds.10431.

Maraganore, DM; Farrer, MJ; Lesnick, TG; de Andrade, M; Bower, JH; Hernandez, D; ... Rocca, WA; + view all (2003) Case-control study of the alpha-synuclein interacting protein gene and Parkinson's disease. MOVEMENT DISORDERS , 18 (11) 1233 - 1239. 10.1002/mds.10547.

Marlow, L; Canet, RM; Haugabook, SJ; Hardy, JA; Lahiri, DK; Sambamurti, K; (2003) APH1, PEN2, and Nicastrin increase A beta levels and gamma-secretase activity. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS , 305 (3) 502 - 509. 10.1016/S0006-291X(03)00797-6.

Miller, RF; Shahmanesh, M; Hanna, MG; Unwin, RJ; Schapira, AHV; Weller, IVD; (2003) Polyphenotypic expression of mitochondrial toxicity caused by nucleoside reverse transcriptase inhibitors. ANTIVIR THER , 8 (3) 253 - 257.

Misbahuddin, A; Placzek, MR; Taanman, JW; Cooper, JM; Warner, TT; (2003) Study of mutant and wild type torsin A in human SH-SY5Y cell lines. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 409 - 409). BRITISH MED JOURNAL PUBL GROUP

Moreau, Y; Aerts, S; De Moor, B; De Strooper, B; Dabrowski, M; (2003) Comparison and meta-analysis of microarray data: from the bench to the computer desk. Trends Genet , 19 (10) 570 - 577.

Morris, CM; O'Brien, KK; Gibson, AM; Hardy, JA; Singleton, AB; (2003) Polymorphism in the human DJ-1 gene is not associated with sporadic dementia with Lewy bodies or Parkinson's disease. NEUROSCIENCE LETTERS , 352 (2) 151 - 153. 10.1016/S0304-3940(03)01030-9.

Morris, HR; Osaki, Y; Holton, J; Lees, AJ; Wood, NW; Revesz, T; Quinn, N; (2003) Tau exon 10 +16 mutation FTDP-17 presenting clinically as sporadic young onset PSP. NEUROLOGY , 61 (1) 102 - 104.

Mundy, HR; Jones, SJ; Hobart, JC; Hanna, MG; Lee, PJ; (2003) A randomized controlled study of modified cobratoxin in adrenomyeloneuropathy. NEUROLOGY , 61 (4) 528 - 530.

Murakami, D; Okamoto, I; Nagano, O; Kawano, Y; Tomita, T; Iwatsubo, T; ... Saya, H; + view all (2003) Presenilin-dependent gamma-secretase activity mediates the intramembranous cleavage of CD44. Oncogene , 22 (10) 1511 - 1516. 10.1038/sj.onc.1206298.

N

Nath, U; Ben-Shlomo, Y; Thomson, RG; Lees, AJ; Burn, DJ; (2003) Clinical features and natural history of progressive supranuclear palsy - A clinical cohort study. NEUROLOGY , 60 (6) 910 - 916.

Nyabi, O; Bentahir, M; Horré, K; Herreman, A; Gottardi-Littell, N; Van Broeckhoven, C; ... De Strooper, B; + view all (2003) Presenilins mutated at Asp-257 or Asp-385 restore Pen-2 expression and Nicastrin glycosylation but remain catalytically inactive in the absence of wild type Presenilin. J Biol Chem , 278 (44) 43430 - 43436. 10.1074/jbc.M306957200.

P

Payami, H; Nutt, J; Gancher, S; Bird, T; McNeal, MG; Seltzer, WK; ... Farrer, M; + view all (2003) SCA2 may present as levodopa-responsive parkinsonism. MOVEMENT DISORDERS , 18 (4) 425 - 429. 10.1002/mds.10375.

Periquet, M; Latouche, M; Lohmann, E; Rawal, N; De Michele, G; Ricard, S; ... European Consortium Genetic Suscep,; + view all (2003) Parkin mutations are frequent in patients with isolated early-onset parkinsonism. BRAIN , 126 1271 - 1278. 10.1093/brain/awg136.

Perry, EK; Kilford, L; Lees, AJ; Burn, DJ; Perry, RH; (2003) Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs. ANN NEUROL , 54 (2) 235 - 238. 10.1002/ana.10639.

Pickford, F; Onstead, L; Camacho-Prihar, C; Hardy, J; McGowan, E; (2003) Expression of mBRI(2) in mice. NEUROSCIENCE LETTERS , 338 (2) 95 - 98. 10.1016/S0304-3940(02)01356-3.

Pitt, M; Houlden, H; Jacobs, J; Mok, Q; Harding, B; Reilly, M; Surtees, R; (2003) Severe infantile neuropathy with diaphragmatic weakness and its relationship to SMARD1. BRAIN , 126 2682 - 2692. 10.1093/brain/awg278.

Pitt, M.; Houlden, H.; Jacobs, J.; Mok, Q.; Harding, B.; Reilly, M.; Surtees, R.; (2003) Severe infantile neuropathy with diaphragmatic weakness and its relationship to SMARD1. Brain , 126 (12) pp. 2682-2692. 10.1093/brain/awg278.

Plun-Favreau, H; Perret, D; Diveu, C; Froger, J; Chevalier, S; Lelievre, E; ... Chabbert, M; + view all (2003) Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor. J BIOL CHEM , 278 (29) 27169 - 27179. 10.1074/jbc.M303168200. Gold open access

Prime, KP; Edwards, SG; Pakianathan, MR; Holton, JL; Scaravilli, F; Miller, RF; (2003) Polymyositis masquerading as mitochondrial toxicity. SEX TRANSM INFECT , 79 (5) 417 - 418.

Proukakis, C; Auer-Grumbach, M; Wagner, K; Wilkinson, PA; Reid, E; Patton, MA; ... Crosby, AH; + view all (2003) Screening of patients with hereditary spastic paraplegia reveals seven novel mutations in the SPG4 (Spastin) gene. Hum Mutat , 21 (2) 170 - ?. 10.1002/humu.9108.

Proukakis, C; Crosby, AH; Auer-Grumbach, M; Wagner, K; Reid, E; Patton, MA; Warner, TT; (2003) Screening of the spastin gene in autosomal dominant hereditary spastic paraplegia reveals seven novel mutations. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 406 - 407). BRITISH MED JOURNAL PUBL GROUP

Pulkes, T; Liolitsa, D; Nelson, IP; Hanna, MG; (2003) Classical mitochondrial phenotypes without mtDNA mutations - The possible role of nuclear genes. NEUROLOGY , 61 (8) 1144 - 1147.

R

Revesz, T; Ghiso, J; Holton, JL; Frangione, B; (2003) Hereditary amyloidoses with neurodegeneration: familial British dementia and familial Danish dementia. In: Dickson, DW, (ed.) Neurodegeneration: the molecular pathology of dementia and movement disorders. (380 - 385). ISN Neuropath Press: Basel.

Revesz, T; Ghiso, J; Lashley, T; Plant, G; Rostagno, A; Frangione, B; Holton, JL; (2003) Cerebral amyloid angiopathies: A pathologic, biochemical, and genetic view. J NEUROPATH EXP NEUR , 62 (9) 885 - 898.

Revesz, T; Holton, JL; (2003) Anatamopathological spectrum of tauopathies. MOVEMENT DISORDERS , 18 S13 - S20. 10.1002/mds.10558.

Rippon, GA; Crook, R; Baker, M; Halvorsen, E; Chin, S; Hutton, M; ... Lynch, T; + view all (2003) Presenilin 1 mutation in an African American family presenting with atypical Alzheimer dementia. ARCH NEUROL-CHICAGO , 60 (6) 884 - 888.

S

Scaravilli, F; Lucas, S; Gray, F; Kuo, L; Hall-Craggs, MA; An, SF; Miller, R; (2003) The changing presentation of encephalitis in AIDs. In: JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY. (pp. 562 - 562). AMER ASSN NEUROPATHOLOGISTS INC

Schott, JM; Paviour, DC; Fox, NC; Stevens, JM; Lees, AJ; Rossor, MN; (2003) Picturing the atrophy patterns of progressive supranuclear palsy and multiple system atrophy in vivo using fluid registered MRI. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 410 - 410). BRITISH MED JOURNAL PUBL GROUP

Schrag, A; Selai, C; Davis, J; Lees, AJ; Jahanshahi, M; Quinn, N; (2003) Health-related quality of life in patients with progressive supranuclear palsy. MOVEMENT DISORD , 18 (12) 1464 - 1469. 10.1002/mds.10583.

Schroeter, EH; Ilagan, MX; Brunkan, AL; Hecimovic, S; Li, YM; Xu, M; ... Kopan, R; + view all (2003) A presenilin dimer at the core of the gamma-secretase enzyme: insights from parallel analysis of Notch 1 and APP proteolysis. Proc Natl Acad Sci U S A , 100 (22) 13075 - 13080. 10.1073/pnas.1735338100.

Schulz, JG; Annaert, W; Vandekerckhove, J; Zimmermann, P; De Strooper, B; David, G; (2003) Syndecan 3 intramembrane proteolysis is presenilin/gamma-secretase-dependent and modulates cytosolic signaling. J Biol Chem , 278 (49) 48651 - 48657. 10.1074/jbc.M308424200.

Schulze, TG; Hardy, J; McMahon, FJ; (2003) Inconsistent designs of association studies: a missed opportunity. MOLECULAR PSYCHIATRY , 8 (9) 770 - 772. 10.1038/sj.mp.4001329.

Seemungal, BM; Faldon, M; Revesz, T; Lees, AJ; Zee, DS; Bronstein, AM; (2003) Influence of target size on vertical gaze palsy in a pathologically proven case of progressive supranuclear palsy. MOVEMENT DISORD , 18 (7) 818 - 822. 10.1002/mds.10434.

Sibbing, D; Trender-Gerhardt, I; Wood, NW; Oertel, WH; Bhatia, KP; Bandmann, O; (2003) The promoter region of the Menkes gene ATP7A is not altered in focal or generalized dystonia. ANN NEUROL , 53 (2) 278 - 279. 10.1002/ana.10436.

Siddiqui, A; Kerb, R; Weale, ME; Brinkmann, U; Smith, A; Goldstein, DB; ... Sisodiya, SM; + view all (2003) Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. NEW ENGL J MED , 348 (15) 1442 - 1448.

Singleton, AB; Farrer, M; Johnson, J; Singleton, A; Hague, S; Kachergus, J; ... Gwinn-Hardy, K; + view all (2003) alpha-synuclein locus triplication causes Parkinson's disease. SCIENCE , 302 (5646) 841 - 841. 10.1126/science.1090278.

Sorajja, P; Sweeney, MG; Chalmers, R; Sachdev, B; Syrris, P; Hanna, M; ... Elliott, PM; + view all (2003) Cardiac abnormalities in patients with Leber's hereditary optic neuropathy. HEART , 89 (7) 791 - 792.

Sultan, R; Hanna, MG; Rahman, S; Isenberg, DA; (2003) International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Journal of Rheumatology , 43 (1) 49 - 54.

Swinn, L; Schrag, A; Viswanathan, R; Bloem, BR; Lees, A; Quinn, N; (2003) Sweating dysfunction in Parkinson's disease. MOVEMENT DISORD , 18 (12) 1459 - 1463. 10.1002/mds.10586.

T

Tabrizi, SJ; Blamire, AM; Manners, DN; Rajagopalan, B; Styles, P; Schapira, AHV; Warner, TT; (2003) Creatine therapy for Huntington's disease: Clinical and MRS findings in a 1-year pilot study. NEUROLOGY , 61 (1) 141 - 142.

Tan, LC; Tanner, CM; Chen, R; Chan, P; Farrer, M; Hardy, J; Langston, JW; (2003) Marked variation in clinical presentation and age of onset in a family with a heterozygous parkin mutation. MOVEMENT DISORDERS , 18 (7) 758 - 763. 10.1002/mds.10432.

U

Ule, J; Jensen, KB; Ruggiu, M; Mele, A; Ule, A; Darnell, RB; (2003) CLIP identifies Nova-regulated RNA networks in the brain. Science , 302 (5648) 1212 - 1215. 10.1126/science.1090095.

V

Valente, EM; Misbahuddin, A; Brancati, F; Placzek, MR; Garavaglia, B; Salvi, S; ... Warner, TT; + view all (2003) Analysis of the epsilon-sarcoglycan gene in familial and sporadic myoclonus-dystonia: Evidence for genetic heterogeneity. MOVEMENT DISORD , 18 (9) 1047 - 1051. 10.1002/mds.10476.

W

Warner, TT; Schapira, AHV; (2003) Genetic and environmental factors in the cause of Parkinson's disease. ANN NEUROL , 53 S16 - S23. 10.1002/ana.10487.

Weale, ME; Depondt, C; Macdonald, SJ; Smith, A; Lai, PS; Shorvon, SD; ... Goldstein, DB; + view all (2003) Selection and evaluation of tagging SNPs in the neuronal-sodium-channel gene SCN1A: Implications for linkage-disequilibrium gene mapping. AM J HUM GENET , 73 (3) 551 - 565.

Weeks, R; Scaravilli, F; Lees, A; Carroll, C; Husain, M; Rudge, P; (2003) Cerebral amyloid angiopathy and motor neurone disease presenting with a progressive supranuclear palsy-like syndrome. Movement Disorders , 18 (3) pp.331 - 336.

Weeks, RA; Scaravilli, F; Lees, AJ; Carroll, C; Husain, M; Rudge, P; (2003) Cerebral amyloid angiopathy and motor neurone disease presenting with a progressive supranuclear palsy-like syndrome. MOVEMENT DISORD , 18 (3) 331 - 336. 10.1002/mds.10347.

Wilkinson, P.A.; Crosby, A.H.; Turner, C.; Patel, H.; Wood, N.W.; Schapira, A.H.; Warner, T.T.; (2003) A clinical and genetic study of SPG5A linked autosomal recessive hereditary spastic paraplegia. Neurology , 61 (2) pp. 235-238.

Wilkinson, PA; Crosby, AH; Turner, C; Patel, H; Wood, NW; Schapira, AH; Warner, TT; (2003) A clinical and genetic study of SPG5A linked autosomal recessive hereditary spastic paraplegia. NEUROLOGY , 61 (2) 235 - 238.

Wilkinson, PA; Hart, PE; Patel, H; Warner, TT; Crosby, AH; (2003) SPG3A mutation screening in English families with early onset autosomal dominant hereditary spastic paraplegia. J NEUROL SCI , 216 (1) 43 - 45. 10.1016/S0022-510X(03)00210-7.

Wood, N; (2003) Principles of genetic counselling. In: EPILEPSIA. (pp. 9 - 9). BLACKWELL PUBLISHING INC

Wood, NW; (2003) Neurogenetics. In: Fowler, TJ and Scadding, JW, (eds.) Clinical neurology. (119 - 129). Arnold: London.

Wood, NW; (2003) Ataxic disorders. In: Warrell, DA and Cox, TM and Firth, JD and Benz, EJ, (eds.) Oxford Textbook of Medicine. (1068 - 1074). Oxford University Press: Oxford.

Wood, NW; (2003) Neurogenetics. In: Warrell, DA and Cox, TM and Firth, JD and Benz, EJ, (eds.) Oxford Textbook of Medicine. (945 - 952). Oxford University Press: Oxford.

Worth, PF; Wood, NW; (2003) A systematic and structured approach to the investigation of ataxia. In: JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. (pp. 1166 - 1166). BRITISH MED JOURNAL PUBL GROUP

Z

Zetterberg, H; Miller, JW; Palmér, M; Boreström, C; Rymo, L; Blennow, K; Green, R; (2003) The transcobalamin codon 259 polymorphism should be designated 776C>G, not 775G>C [2] (multiple letters). Blood , 101 (9) 3749 - 3751. 10.1182/blood-2003-01-0135.

Zetterberg, H; Nexö, E; Regland, B; Minthon, L; Boson, R; Palmér, M; ... Blennow, K; + view all (2003) The transcobalamin (TC) codon 259 genetic polymorphism influences holo-TC concentration in cerebrospinal fluid from patients with Alzheimer disease. Clin Chem , 49 (7) 1195 - 1198.

Zetterberg, H; Palmér, M; Boreström, C; Rymo, L; Blennow, K; (2003) The transcobalamin codon 259 polymorphism should be designated 776C>G, not 775G>C. Blood , 101 (9) 3749 - 3750. 10.1182/blood-2003-01-0084.

Zetterberg, H; Rymo, L; Coppola, A; D'Angelo, A; Spandidos, DA; Blennow, K; (2003) Erratum: MHTFR C677T and A1298C polymorphisms and mutated sequences occuring in cis (European Journal of Human Genetics (2002) vol. 10 (579-582)). European Journal of Human Genetics , 11 (1) 106 - 106. 10.1038/sj.ejhg.5200931.

Zetterberg, H; Wahlund, LO; Blennow, K; (2003) Cerebrospinal fluid markers for prediction of Alzheimer's disease. Neurosci Lett , 352 (1) 67 - 69.

Zetterberg, H; Zafiropoulos, A; Spandidos, DA; Rymo, L; Blennow, K; (2003) Gene-gene interaction between fetal MTHFR 677C>T and transcobalamin 776C>G polymorphisms in human spontaneous abortion. Hum Reprod , 18 (9) 1948 - 1950.

This list was generated on Sun Dec 14 08:33:46 2014 GMT.